• Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease.
  • About 16 million adolescent girls between 15 and 19 give birth each year. In low- and middle-income countries, complications from pregnancy and childbirth are the leading cause of death among girls aged 15 to 19. The Latin American region has one of the highest rates of unintended pregnancies worldwide. Teenage pregnancies in Latin America are linked to a higher incidence of maternal complications during pregnancy and delivery and children of adolescent mothers are at increased risk of preterm birth, low birth weight and neonatal mortality.
  • In September 2017, AHF convened an ISPOR Educational Forum entitled “Evaluation and Discussion of Current Status of HTA in Oncology in Latin America and Consideration of Future Trends”. The forum was sponsored by FIFARMA and took place in ISPOR’s 6th Latin America Conference in São Paulo, Brazil. Three experts from the Americas and one from Europe were invited to present on key issues around the health technology assessment (HTA) for oncology drugs.
  • Immuno-oncology therapies activate the immune system, making it able to recognize cancer cells and destroy them and are expected to become an important part of cancer therapy in years to come. However, the science of immuno-oncology is still evolving. Brazil is a country uniquely primed with both opportunities and strengths for clinical oncology research. Among its strengths, the country counts with growing access to information, an unfortunately high cancer burden, improving patient education, access to new drugs for research centers, regional networks and human resources.
  • In May, AHF partnered with Policy Wisdom to convene a Deliberative Dialogue Day in Sao Paulo Brazil and Bogota, Colombia to discuss the content of an evidence brief about Improving Cancer Care in Latin America (and specifically lung cancer in Colombia).
  • Despite the availability of safe, effective and relatively accessible vaccines, adult vaccination remains at a low level globally, including in Latin America, resulting in millions of adults every year suffering illness, hospitalization and even death from vaccine-preventable diseases.
  • AHF recently convened a consensus conference among expert infectologists and rheumatologists to develop recommendations on vaccination for adults with autoimmune inflammatory rheumatic diseases in Latin America. The resulting paper is currently under review for publication.
  • Following a consensus conference convened by AHF to develop treatment and care recommendations for multiple sclerosis in Central American and the Caribbean, the resulting paper, Esclerosis múltiple en América Central y el Caribe: Estado actual y recomendaciones clínicas was published this month in Revista Mexicana de Neurociencia. Click here for a link to the full article.
  • After almost a year of collaboration, in December AHF convened the final meeting of 2016 of the expert CAM Dengue group whose objectives included analyzing the epidemiology and burden of disease of the dengue virus infection in Central America and the Caribbean and establishing a foundation for a vaccine implementation strategy in the Region.